|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||||||
| Certificates of Deposit with Other Banks | ||||||||||||||||||||
| Total certificates of Deposit with Other Banks | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Available For Sale ("AFS") | ||||||||||||||||||||
| Fair Value, Inputs, Level 3 | ||||||||||||||||||||
| Fair Value, Inputs, Level 2 | ||||||||||||||||||||
| Total available For Sale ("AFS") | ||||||||||||||||||||
| Investment and Mortgage-Backed Securities, Held to Maturity | ||||||||||||||||||||
| Held To Maturity ("HTM") Net of Allowance for Credit Losses of $0 (Fair Value of $130,550 and $130,902 at March 31, 2025 and December 31, 2024, Respectively) | ||||||||||||||||||||
| Fair value, AFS | ||||||||||||||||||||
| Held To Maturity ("HTM") (Fair Value of $111,009 and $130,902 at December 31, 2025 and December 31, 2024, Respectively) | ||||||||||||||||||||
| Total Investments | ||||||||||||||||||||
| Loans Receivable, Net: | ||||||||||||||||||||
| Held For Sale | ||||||||||||||||||||
| Loans and Leases Receivable, Net Amount | ||||||||||||||||||||
| Held For Investment (Net of Allowance for Credit Losses of $14,005 and $13,894 at March 31, 2025 and December 31, 2024, Respectively) | ||||||||||||||||||||
| Total Loans Receivable, Net | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Held For Investment (Net of Allowance of $13,529 and $13,894 at December 31, 2025 and December 31, 2024, Respectively) | ||||||||||||||||||||
| Total Loans Receivable, Net | ||||||||||||||||||||
| Interest Receivable | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Total Accrued Interest Receivable | ||||||||||||||||||||
| Operating Lease Right-of-Use Assets | ||||||||||||||||||||
| Land Held for Sale | ||||||||||||||||||||
| Premises and Equipment, Net | ||||||||||||||||||||
| Federal Home Loan Bank ("FHLB") Stock, at Cost | ||||||||||||||||||||
| Other Real Estate Owned ("OREO") | ||||||||||||||||||||
| Bank Owned Life Insurance ("BOLI") | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Deposit Accounts | ||||||||||||||||||||
| Advances from FHLB | ||||||||||||||||||||
| Fair Value, Inputs, Level 3 | ||||||||||||||||||||
| Fair Value, Inputs, Level 2 | ||||||||||||||||||||
| Total advances from FHLB | ||||||||||||||||||||
| Borrowings from Federal Reserve Bank ("FRB") | ||||||||||||||||||||
| Allowance For Loan Losses | ||||||||||||||||||||
| Common Stock Par Value Per Share | ||||||||||||||||||||
| Common Stock Shares Authorized | ||||||||||||||||||||
| Common Stock Shares Issued | ||||||||||||||||||||
| Common Stock, Shares, Outstanding | ||||||||||||||||||||
| Other Borrowings | ||||||||||||||||||||
| Junior Subordinated Debentures | ||||||||||||||||||||
| Fair Value, Inputs, Level 3 | ||||||||||||||||||||
| Fair Value, Inputs, Level 2 | ||||||||||||||||||||
| Total junior Subordinated Debentures | ||||||||||||||||||||
| Subordinated Debentures | ||||||||||||||||||||
| Fair Value, Inputs, Level 3 | ||||||||||||||||||||
| Fair Value, Inputs, Level 2 | ||||||||||||||||||||
| Total subordinated Debentures | ||||||||||||||||||||
| Operating Lease Liabilities | ||||||||||||||||||||
| Other Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders' Equity: | ||||||||||||||||||||
| Senior Non-Cumulative Perpetual Preferred Stock, Series ECIP, $1,000 Par Value; 82,949 Shares Authorized, Issued and Outstanding at March 31, 2023 and December 31, 2022 | ||||||||||||||||||||
| Common Stock, $0.01 Par Value; 5,000,000 Shares Authorized; 3,454,143 and 3,453,817 Shares Issued and 3,253,210 and 3,252,884 Shares Outstanding at March 31, 2023 and December 31, 2022, Respectively | ||||||||||||||||||||
| Senior Non-Cumulative Perpetual Preferred Stock, Series ECIP, $1,000 Par Value; (82,949 Shares Authorized, Issued and Outstanding at December 31, 2025 and 2024) | ||||||||||||||||||||
| Common Stock, $0.01 Par Value; 5,000,000 Shares Authorized; 3,459,388 Shares Issued and 3,113,843 Shares Outstanding at December 31, 2025 and 3,458,050 Shares Issued and 3,186,571 Shares Outstanding at December 31, 2024 | ||||||||||||||||||||
| Additional Paid-In Capital ("APIC") | ||||||||||||||||||||
| Debt Securities, Held-to-maturity, Fair Value | ||||||||||||||||||||
| Treasury Stock, at Cost (345,545 and 271,479 Shares Outstanding at December 31, 2025 and 2024, Respectively) | ||||||||||||||||||||
| Accumulated Other Comprehensive Loss ("AOCL") | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Total Shareholders' Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders' Equity | ||||||||||||||||||||
Loading...